We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Petros Pharmaceuticals Inc | NASDAQ:PTPI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0033 | -0.46% | 0.71 | 0.68 | 0.71 | 5,845 | 13:35:57 |
NEW YORK, May 7, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced that management will participate at the Benzinga Global Small Cap Conference on May 13, 2021.
President and Chief Commercial Officer Fady Boctor will deliver his corporate presentation at 10:50am ET on May 13, 2021.
Investors can also request a one-on-one meeting with Mr. Boctor to be arranged following the conclusion of the conference.
Investors can register for the conference here:
https://www.benzinga.com/events/small-cap/global/.
About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.
View original content:http://www.prnewswire.com/news-releases/petros-pharmaceuticals-to-participate-at-the-benzinga-global-small-cap-conference-and-present-to-investors-on-may-13-2021-301286412.html
SOURCE Petros Pharmaceuticals, Inc.
Copyright 2021 PR Newswire
1 Year Petros Pharmaceuticals Chart |
1 Month Petros Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions